Target intelligence / Profile preview

HSV entry receptors

Molecular classification
Immunoglobulin superfamily, Tumor necrosis factor receptor superfamily, Heparan sulfate proteoglycan, Receptor
01

Overview

HSV entry receptors are a group of cellular proteins that facilitate the binding, fusion, and penetration of herpes simplex virus into host cells. The major known HSV entry receptors include nectin-1 and nectin-2 (immunoglobulin superfamily adhesion molecules), HVEM (a member of the tumor necrosis factor receptor family), and 3-O-sulfated heparan sulfate. For HSV-1, PILRα has also been identified as a gB coreceptor in certain cell types. These receptors have non-redundant physiological functions in cell adhesion and immune modulation but are hijacked by HSV to mediate entry. The type of receptor used varies by cell type and viral strain, and multiple receptors may be used in parallel or redundantly. Antiviral strategies have focused on blocking these interactions, but their physiological roles complicate direct targeting.

Other names
HSV entry coreceptorsHerpes simplex virus entry receptorsHSV gD receptorsHSV gB receptor
02

Mechanism of action

Competitive inhibition of viral attachment or fusion (soluble receptors/antibodies block access to cellular receptors) Preventing conformational change in viral glycoproteins required for membrane fusion and entry Inhibiting virus spread and cell-cell fusion

03

Biological functions

Virus entry and cell fusionImmune signalingCell adhesion
04

Disease associations

Infection
05

Safety considerations

Targeting ubiquitously expressed receptors (such as nectin-1, HVEM) may impact essential physiological processes, including immune signaling and cell adhesionPotential immune modulation or off-target effects due to functions of these molecules outside viral entry
06

Interacting drugs

Recombinant soluble forms of receptors (e.g., soluble nectin-1 or HVEM)

2 more in the full profile.

07

Biomarkers

No established use of HSV entry receptor expression as clinical biomarkers for patient selection or therapeutic efficacy.

Beyond the preview

Go deeper on HSV entry receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HSV entry receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call